Triglyceride absorption

“Triglyceride absorption” is **not** the name of a specific molecule, protein, receptor, enzyme, or transporter. Instead, it refers to the physiological process by which dietary triglycerides are digested and absorbed in the small intestine. This multi-step process involves several key components: * **Emulsification:** Dietary triglycerides are first emulsified by bile acids secreted from the gallbladder into smaller droplets to increase surface area[1][2][3][5]. * **Enzymatic digestion:** Pancreatic lipase hydrolyzes triglycerides into monoglycerides and free fatty acids[1][2][3]. * **Micelle formation:** Bile salts form micelles with monoglycerides and fatty acids to facilitate their transport across the aqueous environment of the intestinal lumen[2][3]. * **Absorption into enterocytes:** Monoglycerides and fatty acids diffuse or are transported into enterocytes lining the small intestine[1][2]. * **Re-synthesis & chylomicron formation:** Inside enterocytes, these products are reassembled into triglycerides and packaged with proteins as chylomicrons for release into lymphatics/bloodstream[1][4][5]. This process is essential for normal nutrition but is not itself a druggable “target.” Instead, individual molecules within this pathway—such as pancreatic lipase (enzyme), bile acid transporters (transporter), or apical membrane fatty acid transport proteins—may be considered therapeutic targets. Because “triglyceride absorption” does not refer to any single molecular entity but rather an entire physiological pathway involving multiple steps and molecules, **it should not be classified as a canonical drug target**. If you require structured information on actual targets within this pathway (e.g., pancreatic lipase), please specify that molecule/protein/enzyme/transporter by name.

Other names

Triglyceride absorptionLipid absorptionFat absorption